Inter-joint coordination with and without dopaminergic medication in Parkinson's disease: a case-control study.


Journal

Journal of neuroengineering and rehabilitation
ISSN: 1743-0003
Titre abrégé: J Neuroeng Rehabil
Pays: England
ID NLM: 101232233

Informations de publication

Date de publication:
13 Jul 2024
Historique:
received: 27 03 2024
accepted: 04 07 2024
medline: 14 7 2024
pubmed: 14 7 2024
entrez: 13 7 2024
Statut: epublish

Résumé

How the joints exactly move and interact and how this reflects PD-related gait abnormalities and the response to dopaminergic treatment is poorly understood. A detailed understanding of these kinematics can inform clinical management and treatment decisions. The aim of the study was to investigate the influence of different gait speeds and medication on/off conditions on inter-joint coordination, as well as kinematic differences throughout the whole gait cycle in well characterized pwPD. 29 controls and 29 PD patients during medication on, 8 of them also during medication off walked a straight walking path in slow, preferred and fast walking speeds. Gait data was collected using optical motion capture system. Kinematics of the hip and knee and coordinated hip-knee kinematics were evaluated using Statistical Parametric Mapping (SPM) and cyclograms (angle-angle plots). Values derived from cyclograms were compared using repeated-measures ANOVA for within group, and ttest for between group comparisons. PD gait differed from controls mainly by lower knee range of motion (ROM). Adaptation to gait speed in PD was mainly achieved by increasing hip ROM. Regularity of gait was worse in PD but only during preferred speed. The ratios of different speed cyclograms were smaller in the PD groups. SPM analyses revealed that PD participants had smaller hip and knee angles during the swing phase, and PD participants reached peak hip flexion later than controls. Withdrawal of medication showed an exacerbation of only a few parameters. Our findings demonstrate the potential of granular kinematic analyses, including > 1 joint, for disease and treatment monitoring in PD. Our approach can be extended to further mobility-limiting conditions and other joint combinations. The study is registered in the German Clinical Trials Register (DRKS00022998, registered on 04 Sep 2020).

Sections du résumé

BACKGROUND BACKGROUND
How the joints exactly move and interact and how this reflects PD-related gait abnormalities and the response to dopaminergic treatment is poorly understood. A detailed understanding of these kinematics can inform clinical management and treatment decisions. The aim of the study was to investigate the influence of different gait speeds and medication on/off conditions on inter-joint coordination, as well as kinematic differences throughout the whole gait cycle in well characterized pwPD.
METHODS METHODS
29 controls and 29 PD patients during medication on, 8 of them also during medication off walked a straight walking path in slow, preferred and fast walking speeds. Gait data was collected using optical motion capture system. Kinematics of the hip and knee and coordinated hip-knee kinematics were evaluated using Statistical Parametric Mapping (SPM) and cyclograms (angle-angle plots). Values derived from cyclograms were compared using repeated-measures ANOVA for within group, and ttest for between group comparisons.
RESULTS RESULTS
PD gait differed from controls mainly by lower knee range of motion (ROM). Adaptation to gait speed in PD was mainly achieved by increasing hip ROM. Regularity of gait was worse in PD but only during preferred speed. The ratios of different speed cyclograms were smaller in the PD groups. SPM analyses revealed that PD participants had smaller hip and knee angles during the swing phase, and PD participants reached peak hip flexion later than controls. Withdrawal of medication showed an exacerbation of only a few parameters.
CONCLUSIONS CONCLUSIONS
Our findings demonstrate the potential of granular kinematic analyses, including > 1 joint, for disease and treatment monitoring in PD. Our approach can be extended to further mobility-limiting conditions and other joint combinations.
TRIAL REGISTRATION BACKGROUND
The study is registered in the German Clinical Trials Register (DRKS00022998, registered on 04 Sep 2020).

Identifiants

pubmed: 39003450
doi: 10.1186/s12984-024-01416-8
pii: 10.1186/s12984-024-01416-8
doi:

Substances chimiques

Dopamine Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

118

Informations de copyright

© 2024. The Author(s).

Références

Viteckova S, Kutilek P, Svoboda Z, Krupicka R, Kauler J, Szabo Z. Gait symmetry measures: a review of current and prospective methods. Biomed Signal Process Control. 2018;42:89–100.
doi: 10.1016/j.bspc.2018.01.013
Roemmich RT, Field AM, Elrod JM, Stegemöller EL, Okun MS, Hass CJ. Interlimb coordination is impaired during walking in persons with Parkinson’s disease. Clin Biomech. 2013;28(1):93–7.
doi: 10.1016/j.clinbiomech.2012.09.005
Baltadjieva R, Giladi N, Gruendlinger L, Peretz C, Hausdorff JM. Marked alterations in the gait timing and rhythmicity of patients with de novo Parkinson’s disease. Eur J Neurosci. 2006;24(6):1815–20.
pubmed: 17004944 doi: 10.1111/j.1460-9568.2006.05033.x
Rudzińska M, Bukowczan S, Banaszkiewicz K, Stozek J, Zajdel K, Szczudlik A. Causes and risk factors of falls in patients with Parkinson’s disease. Neurol Neurochir Pol. 2008;42(3):216–22.
pubmed: 18651327
Wood BH, Bilclough JA, Bowron A, Walker RW. Incidence and prediction of falls in Parkinson’s disease: a prospective multidisciplinary study. J Neurol Neurosurg Psychiatry. 2002;72(6):721–5.
pubmed: 12023412 pmcid: 1737913 doi: 10.1136/jnnp.72.6.721
Pickering RM, Grimbergen YAM, Rigney U, Ashburn A, Mazibrada G, Wood B, et al. A meta-analysis of six prospective studies of falling in Parkinson’s disease. Mov Disord off J Mov Disord Soc. 2007;22(13):1892–900.
doi: 10.1002/mds.21598
Curtze C, Nutt JG, Carlson-Kuhta P, Mancini M, Horak FB. Levodopa is a double-edged Sword for Balance and Gait in People with Parkinson’s Disease. Mov Disord. 2015;30(10):1361–70.
pubmed: 26095928 pmcid: 4755510 doi: 10.1002/mds.26269
Warmerdam E, Romijnders R, Hansen C, Elshehabi M, Zimmermann M, Metzger FG, et al. Arm swing responsiveness to dopaminergic medication in Parkinson’s disease depends on task complexity. Npj Park Dis. 2021;7(1):1–7.
An KN, Chao EY. Kinematic analysis of human movement. Ann Biomed Eng. 1984;12(6):585–97.
pubmed: 6534225 doi: 10.1007/BF02371451
Sotirakis C, Su Z, Brzezicki MA, Conway N, Tarassenko L, FitzGerald JJ, et al. Identification of motor progression in Parkinson’s disease using wearable sensors and machine learning. NPJ Park Dis. 2023;9:142.
doi: 10.1038/s41531-023-00581-2
Agurto C, Heisig S, Abrami A, Ho BK, Caggiano V. Parkinson’s disease medication state and severity assessment based on coordination during walking. PLoS ONE. 2021;16(2):e0244842.
pubmed: 33596202 pmcid: 7888646 doi: 10.1371/journal.pone.0244842
Hansen C, Chebil B, Cockroft J, Bianchini E, Romijnders R, Maetzler W. Changes in coordination and its variability with an increase in functional performance of the Lower extremities. Biosensors. 2023;13(2):156.
pubmed: 36831922 pmcid: 9953305 doi: 10.3390/bios13020156
Dubois O, Roby-Brami A, Parry R, Khoramshahi M, Jarrassé N. A guide to inter-joint coordination characterization for discrete movements: a comparative study. J Neuroeng Rehabil. 2023;20:132.
pubmed: 37777814 pmcid: 10543874 doi: 10.1186/s12984-023-01252-2
Forner-Cordero A, Levin O, Li Y, Swinnen SP. Principal component analysis of complex multijoint coordinative movements. Biol Cybern. 2005;93(1):63–78.
pubmed: 16021517 doi: 10.1007/s00422-005-0582-y
Reisman DS, Block HJ, Bastian AJ. Interlimb coordination during locomotion: what can be adapted and stored? J Neurophysiol. 2005;94(4):2403–15.
pubmed: 15958603 doi: 10.1152/jn.00089.2005
Krasovsky T, Baniña MC, Hacmon R, Feldman AG, Lamontagne A, Levin MF. Stability of gait and interlimb coordination in older adults. J Neurophysiol. 2012;107(9):2560–9.
pubmed: 22298827 doi: 10.1152/jn.00950.2011
Ma L, Mi TM, Jia Q, Han C, Chhetri JK, Chan P. Gait variability is sensitive to detect Parkinson’s disease patients at high fall risk. Int J Neurosci. 2022;132(9):888–93.
pubmed: 33256488 doi: 10.1080/00207454.2020.1849189
Sidoroff V, Raccagni C, Kaindlstorfer C, Eschlboeck S, Fanciulli A, Granata R, et al. Characterization of gait variability in multiple system atrophy and Parkinson’s disease. J Neurol. 2021;268(5):1770–9.
pubmed: 33382439 doi: 10.1007/s00415-020-10355-y
Bryant MS, Rintala DH, Hou JG, Collins RL, Protas EJ. Gait variability in Parkinson’s disease: levodopa and walking direction. Acta Neurol Scand. 2016;134(1):83–6.
pubmed: 26399376 doi: 10.1111/ane.12505
Mukli P, Detwiler S, Owens CD, Csipo T, Lipecz A, Pinto CB, et al. Gait variability predicts cognitive impairment in older adults with subclinical cerebral small vessel disease. Front Aging Neurosci. 2022;14:1052451.
pubmed: 36466602 pmcid: 9716182 doi: 10.3389/fnagi.2022.1052451
Barbe MT, Amarell M, Snijders AH, Florin E, Quatuor EL, Schönau E, et al. Gait and upper limb variability in Parkinson’s disease patients with and without freezing of gait. J Neurol. 2014;261(2):330–42.
pubmed: 24305993 doi: 10.1007/s00415-013-7199-1
Arippa F, Leban B, Monticone M, Cossu G, Casula C, Pau M. A study on Lower Limb asymmetries in Parkinson’s Disease during Gait assessed through kinematic-derived parameters. Bioengineering. 2022;9(3):120.
pubmed: 35324809 pmcid: 8945156 doi: 10.3390/bioengineering9030120
Awai L, Curt A. Intralimb coordination as a sensitive indicator of motor-control impairment after spinal cord injury. Front Hum Neurosci. 2014;8:148.
pubmed: 24672464 pmcid: 3956041 doi: 10.3389/fnhum.2014.00148
Pincheira PA, De La Maza E, Silvestre R, Guzmán-Venegas R, Becerra M. Comparison of total hip arthroplasty surgical approaches by statistical Parametric Mapping. Clin Biomech Bristol Avon. 2019;62:7–14.
pubmed: 30639965 doi: 10.1016/j.clinbiomech.2018.12.024
Pataky TC, Robinson MA, Vanrenterghem J. Vector field statistical analysis of kinematic and force trajectories. J Biomech. 2013;46(14):2394–401.
pubmed: 23948374 doi: 10.1016/j.jbiomech.2013.07.031
Donnelly CJ, Alexander C, Pataky TC, Stannage K, Reid S, Robinson MA. Vector-field statistics for the analysis of time varying clinical gait data. Clin Biomech. 2017;41:87–91.
doi: 10.1016/j.clinbiomech.2016.11.008
O’Sullivan R, French H, Horgan F. A prospective assessment of gait kinematics and related clinical examination measures in cerebral palsy crouch gait. HRB Open Res. 2023;5:81.
pubmed: 37601116 pmcid: 10435924 doi: 10.12688/hrbopenres.13647.2
Fernández-Vázquez D, Calvo-Malón G, Molina-Rueda F, López-González R, Carratalá-Tejada M, Navarro-López V, et al. Kinematic Gait Analysis in people with mild-disability multiple sclerosis using statistical Parametric Mapping: a cross-sectional study. Sensors. 2023;23(18):7671.
pubmed: 37765727 pmcid: 10535645 doi: 10.3390/s23187671
Ribeiro Artigas N, Eltz GD, do Pinho AS, Torman VBL, Hilbig A, Rieder CRM. Evaluation of knee proprioception and factors related to Parkinson’s Disease. Neurosci J. 2016;2016:6746010.
pubmed: 27672650 pmcid: 5031852 doi: 10.1155/2016/6746010
Djaldetti R, Hellmann M, Melamed E. Bent knees and tiptoeing: late manifestations of end-stage Parkinson’s disease. Mov Disord. 2004;19(11):1325–8.
pubmed: 15389997 doi: 10.1002/mds.20187
Wright WG, Gurfinkel VS, Nutt J, Horak FB, Cordo PJ. Axial hypertonicity in Parkinson’s disease: direct measurements of trunk and hip torque. Exp Neurol. 2007;208(1):38–46.
pubmed: 17692315 pmcid: 2144734 doi: 10.1016/j.expneurol.2007.07.002
Warmerdam E, Romijnders R, Geritz J, Elshehabi M, Maetzler C, Otto JC, et al. Proposed mobility assessments with Simultaneous Full-Body Inertial Measurement Units and Optical Motion capture in healthy adults and neurological patients for future validation studies: study protocol. Sensors. 2021;21(17):5833.
pubmed: 34502726 pmcid: 8434336 doi: 10.3390/s21175833
von der Recke F, Warmerdam E, Hansen C, Romijnders R, Maetzler W. Reduced range of Gait Speed: a Parkinson’s Disease-Specific Symptom? J Park Dis. 2023;13(2):197–202.
Lin CC, Creath RA, Rogers MW. Variability of anticipatory postural adjustments during gait initiation in individuals with Parkinson Disease. J Neurol Phys Ther JNPT. 2016;40(1):40–6.
pubmed: 26630325 doi: 10.1097/NPT.0000000000000112
Poldrack RA, Markiewicz CJ, Appelhoff S, Ashar YK, Auer T, Baillet S et al. The Past, Present, and Future of the Brain Imaging Data Structure (BIDS). ArXiv. 2023;arXiv:2309.05768v1.
Gløersen Ø, Federolf P. Predicting missing marker trajectories in human Motion Data using marker intercorrelations. PLoS ONE. 2016;11(3):e0152616.
pubmed: 27031243 pmcid: 4816448 doi: 10.1371/journal.pone.0152616
Romijnders R, Warmerdam E, Hansen C, Schmidt G, Maetzler W. A Deep Learning Approach for Gait Event detection from a single Shank-worn IMU: validation in healthy and neurological cohorts. Sensors. 2022;22(10):3859.
pubmed: 35632266 pmcid: 9143761 doi: 10.3390/s22103859
Saegner K, Romijnders R. Joint Angle extration [Internet]. 2023. https://github.com/neurogeriatricskiel/MocapJointAngles
Pataky T. spm1d [Internet]. 2023. https://spm1d.org/
Cicirelli G, Impedovo D, Dentamaro V, Marani R, Pirlo G, D’Orazio T. Human gait analysis in neurodegenerative diseases: a review. IEEE J Biomed Health Inf. 2021;PP:1–1.
Peters SAE, Groenwold RHH, Bots ML. [Intermediate endpoints in clinical research]. Ned Tijdschr Geneeskd. 2013;157(43):A6400.
pubmed: 24152361
Mentiplay BF, Banky M, Clark RA, Kahn MB, Williams G. Lower limb angular velocity during walking at various speeds. Gait Posture. 2018;65:190–6.
pubmed: 30558929 doi: 10.1016/j.gaitpost.2018.06.162
de ShidaTKF CEN, da Silva Fragoso D, Los Angeles E, Bernardo C, dos, Santos de Oliveira L et al. Effect of freezing of gait and dopaminergic medication in the biomechanics of lower limbs in the gait of patients with Parkinson’s disease compared to neurologically healthy. Neurosci Lett. 2023;806:137250.
Blin O, Ferrandez AM, Pailhous J, Serratrice G. Dopa-sensitive and dopa-resistant gait parameters in Parkinson’s disease. J Neurol Sci. 1991;103(1):51–4.
pubmed: 1865232 doi: 10.1016/0022-510X(91)90283-D
Ohara M, Hirata K, Hallett M, Matsubayashi T, Chen Q, Kina S, et al. Long-term levodopa ameliorates sequence effect in simple, but not complex walking in early Parkinson’s disease patients. Parkinsonism Relat Disord. 2023;108:105322.
pubmed: 36822140 pmcid: 10082924 doi: 10.1016/j.parkreldis.2023.105322
Tosserams A, Bloem BR, Ehgoetz Martens KA, Helmich RC, Kessels RPC, Shine JM, et al. Modulating arousal to overcome gait impairments in Parkinson’s disease: how the noradrenergic system may act as a double-edged sword. Transl Neurodegener. 2023;12:15.
pubmed: 36967402 pmcid: 10040128 doi: 10.1186/s40035-023-00347-z
Pohl M, Rockstroh G, Rückriem S, Mrass G, Mehrholz J. Immediate effects of speed-dependent treadmill training on gait parameters in early Parkinson’s disease1. Arch Phys Med Rehabil. 2003;84(12):1760–6.
pubmed: 14669180 doi: 10.1016/S0003-9993(03)00433-7
Shulman LM, Katzel LI, Ivey FM, Sorkin JD, Favors K, Anderson KE, et al. Randomized Clinical Trial of 3 types of Physical Exercise for patients with Parkinson Disease. JAMA Neurol. 2013;70(2):183–90.
pubmed: 23128427 pmcid: 4574905 doi: 10.1001/jamaneurol.2013.646
Protas EJ, Mitchell K, Williams A, Qureshy H, Caroline K, Lai EC. Gait and step training to reduce falls in Parkinson’s disease. NeuroRehabilitation. 2005;20(3):183–90.
pubmed: 16340099 doi: 10.3233/NRE-2005-20305
Scandalis TA, Bosak A, Berliner JC, Helman LL, Wells MR. Resistance Training and gait function in patients with Parkinson’s Disease. Am J Phys Med Rehabil. 2001;80(1):38.
pubmed: 11138953 doi: 10.1097/00002060-200101000-00011
Sofuwa O, Nieuwboer A, Desloovere K, Willems AM, Chavret F, Jonkers I. Quantitative gait analysis in Parkinson’s disease: comparison with a healthy control group. Arch Phys Med Rehabil. 2005;86(5):1007–13.
pubmed: 15895349 doi: 10.1016/j.apmr.2004.08.012
Romijnders R, Salis F, Hansen C, Küderle A, Paraschiv-Ionescu A, Cereatti A, et al. Ecological validity of a deep learning algorithm to detect gait events from real-life walking bouts in mobility-limiting diseases. Front Neurol. 2023;14:1247532.
pubmed: 37909030 pmcid: 10615212 doi: 10.3389/fneur.2023.1247532
Storm FA, Buckley CJ, Mazzà C. Gait event detection in laboratory and real life settings: accuracy of ankle and waist sensor based methods. Gait Posture. 2016;50:42–6.
pubmed: 27567451 doi: 10.1016/j.gaitpost.2016.08.012
Warmerdam E, Hansen C, Romijnders R, Hobert MA, Welzel J, Maetzler W. Full-body mobility data to Validate Inertial Measurement Unit Algorithms in healthy and neurological cohorts. Data. 2022;7(10):136.
doi: 10.3390/data7100136

Auteurs

Karolina Saegner (K)

Department of Neurology, University Hospital Schleswig-Holstein, Campus Kiel and Kiel University, Arnold-Heller Str. 3, Kiel, 24105, Germany. karolina.saegner@uksh.de.

Robbin Romijnders (R)

Department of Neurology, University Hospital Schleswig-Holstein, Campus Kiel and Kiel University, Arnold-Heller Str. 3, Kiel, 24105, Germany.

Clint Hansen (C)

Department of Neurology, University Hospital Schleswig-Holstein, Campus Kiel and Kiel University, Arnold-Heller Str. 3, Kiel, 24105, Germany.

Jana Holder (J)

Department of Sport and Exercise Science, University of Salzburg, Salzburg, Austria.

Elke Warmerdam (E)

Department of Neurology, University Hospital Schleswig-Holstein, Campus Kiel and Kiel University, Arnold-Heller Str. 3, Kiel, 24105, Germany.
Werner Siemens-Endowed Chair for Innovative Implant Development (Fracture Healing), Saarland University, Homburg, 66421, Germany.

Walter Maetzler (W)

Department of Neurology, University Hospital Schleswig-Holstein, Campus Kiel and Kiel University, Arnold-Heller Str. 3, Kiel, 24105, Germany. w.maetzler@neurologie.uni-kiel.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH